M&A Deal Summary

Baxter International Acquires Claris Injectables

On December 15, 2016, Baxter International acquired medical products company Claris Injectables from Claris Lifesciences for 625M USD

Acquisition Highlights
  • This is Baxter International’s 8th transaction in the Medical Products sector.
  • This is Baxter International’s 4th largest (disclosed) transaction.
  • This is Baxter International’s 1st transaction in India.

M&A Deal Summary
Date 2016-12-15
Target Claris Injectables
Sector Medical Products
Buyer(s) Baxter International
Sellers(s) Claris Lifesciences
Deal Type Divestiture
Deal Value 625M USD

Target

Claris Injectables

Ahmedabad, India
website
Claris Injectables Ltd. is a manufacturer and marketer of essential medicines across multiple delivery systems and segments, including anesthesia and analgesics; blood products; anti-infectives; critical care and nephrology. Its manufacturing facilities are registered with global regulatory agencies including the FDA and authorities in the UK, Australia, Brazil and Middle East.

Search 192,611 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Baxter International

Deerfield, Illinois, United States

website

Category Company
Founded 1931
Sector Medical Products
Employees60,000
Revenue 15.1B USD (2022)
DESCRIPTION
Entrance to Baxter International's corporate headquarters in Deerfield, Illinois.
Entrance to Baxter International's corporate headquarters in Deerfield, Illinois.

Baxter International develops, manufactures and markets drugs and medical products for people with a variety of medical conditions. Baxter's operations are comprised of the BioScience and Medical Products segments. The BioScience business processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines. The Medical Products business manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. The business also provides products and services related to pharmacy compounding, drug formulation and packaging technologies. In addition, the Medical Products business provides products and services to treat end-stage renal disease, or irreversible kidney failure. Baxter International was founded in 1931 and is based in Deerfield, Illinois.

DEAL STATS #
Overall 15 of 20
Sector (Medical Products) 8 of 12
Type (Divestiture) 3 of 6
Country (India) 1 of 1
Year (2016) 1 of 1
Size (of disclosed) 4 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-06-05 Baxalta

Deerfield, Illinois, United States

Baxalta Incorporated is a global biopharmaceutical company developing, manufacturing and commercializing therapies for orphan diseases and underserved conditions in hematology, oncology and immunology.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-03-19 Mallinckrodt - Recothrom and Preveleak

Dublin, Ireland

Mallinckrodt plc - Recothrom and Preveleak is a provider of stand-alone recombinant thrombin and Surgical Sealant is used in vascular reconstruction.

Buy -

Seller(S) 1

SELLER

Claris Lifesciences

Ahmedabad, India

website

Category Company
Sector Life Science
DESCRIPTION

Claris Lifesciences Ltd. manufactures and markets sterile parenteral preparations, life saving medicines and other hospital care products. Claris has a special focus on the delivery systems used for administering these drugs and has developed specialized products in that area.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
Country (India) 1 of 1
Year (2016) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal